
@ShahidNShah
Patient demand, specialty drug availability and workforce shortages have driven increases in home infusion therapy. Health systems and specialty companies can administer prescription drugs intravenously in a home setting to sidestep overhead fees on brick-and-mortar operations and to reserve clinical space for more acute cases. Payers also tout potential savings.
As the practice grows, however, industry watchers are raising questions about whether cost and safety considerations could undermine its possible advantages.
To improve patient safety and cost-effectiveness in home infusion therapy (HIT), hospitals and health-tech innovators should focus on comprehensive patient screening protocols, robust training and education programs, advanced monitoring technologies, collaboration with payers and policymakers, and continuous quality improvement initiatives. By implementing these strategies, stakeholders can ensure the suitability of patients for HIT, enhance healthcare professionals' competency, utilize remote monitoring and smart infusion pumps, address reimbursement challenges, and drive ongoing improvement. These actions will contribute to safer and more efficient HIT, allowing patients to receive long-term intravenous treatments in their homes while minimizing risks and optimizing resource utilization.
Continue reading at modernhealthcare.com
The Centers for Disease Control and Prevention reported that in 2021, 37% of adults had used telehealth services in the last twelve months. Telehealth can be provided through video chats, remote …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm